Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
Larsen, S G, Goscinski, M A, Dueland, S, Steigen, S E, Hofsli, E, Torgunrud, A, Lund-Iversen, M, Dagenborg, V J, Flatmark, K, Sorbye, H
Published in British journal of cancer (23.03.2022)
Published in British journal of cancer (23.03.2022)
Get full text
Journal Article
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
Sorbye, H., Welin, S., Langer, S.W., Vestermark, L.W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M.G., Ohrling, K., Birkemeyer, E., Thiis-Evensen, E., Biagini, M., Gronbaek, H., Soveri, L.M., Olsen, I.H., Federspiel, B., Assmus, J., Janson, E.T., Knigge, U.
Published in Annals of oncology (01.01.2013)
Published in Annals of oncology (01.01.2013)
Get full text
Journal Article
Identification of serum microRNA profiles in colon cancer
HOFSLI, E, SJURSEN, W, PRESTVIK, W. S, JOHANSEN, J, RYE, M, TRANØ, G, WASMUTH, H. H, HATLEVOLL, I, THOMMESEN, L
Published in British journal of cancer (30.04.2013)
Published in British journal of cancer (30.04.2013)
Get full text
Journal Article
Physical exercise during adjuvant chemotherapy for colorectal cancer—a non-randomized feasibility study
Hatlevoll, I., Oldervoll, L. M., Wibe, A., Stene, G. B., Stafne, S. N., Hofsli, E.
Published in Supportive care in cancer (01.06.2021)
Published in Supportive care in cancer (01.06.2021)
Get full text
Journal Article
NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)
Winther, S B, Skuladottir, H, Hofsli, E, Shah, C-H, Yilmaz, M K, Österlund, P J, Berglund, Å, Glimelius, B, Qvortrup, C, Sorbye, H, Pfeiffer, P
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study
TRANØ, G, SJURSEN, W, WASMUTH, H. H, HOFSLI, E, VATTEN, L. J
Published in British journal of cancer (02.02.2010)
Published in British journal of cancer (02.02.2010)
Get full text
Journal Article
Identification of novel neuroendocrine-specific tumour genes
HOFSLI, E, WHEELER, T. E, LANGAAS, M, LAEGREID, A, THOMMESEN, L
Published in British journal of cancer (21.10.2008)
Published in British journal of cancer (21.10.2008)
Get full text
Journal Article
Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study
Tranø, G., Wasmuth, H. H., Sjursen, W., Hofsli, E., Vatten, L. J.
Published in Colorectal disease (01.06.2009)
Published in Colorectal disease (01.06.2009)
Get full text
Journal Article
Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
HOFSLI, E, THOMMESEN, L, YADETIE, F, LANGAAS, M, KUSNIERCZYK, W, FALKMER, U, SANDVIK, A. K, LAEGREID, A
Published in British journal of cancer (25.04.2005)
Published in British journal of cancer (25.04.2005)
Get full text
Journal Article
632P Predictive value of C-reactive protein (CRP) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) patients given first-line alternating short-course oxaliplatin-based chemotherapy (FLOX) and nivolumab
Meltzer, S., Berg, J.P., Hamre, H.M., Kersten, C., Hofsli, E., Guren, M.G., Sorbye, H., Flatmark, K., Ree, A.H.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
SO-33 The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – a post-hoc exploratory analysis of the randomized NORDIC9-study
Liposits, G., Jesper, R., Winther, S., Skuladottir, H., Möller, S., Hofsli, E., Shah, C., Poulsen, L., î Berglund, Qvortrup, C., Osterlund, P., Glimelius, B., Sorbye, H., Pfeiffer, P.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
543P Tumor mutational burden (TMB), BRAF status, and C-reactive protein (CRP) predict response to first-line alternating oxaliplatin-based chemotherapy and nivolumab in metastatic microsatellite-stable (MSS) colorectal cancer (CRC)
Ree, A.H., Bousquet, P.A., Nilsen, H.L., Lüders, T., Wang, S., Visnovska, T., Bordin, D.L., Høye, E., Hamre, H.M., Kersten, C., Hofsli, E., Guren, M.G., Sorbye, H., Berg, J.P., Flatmark, K., Meltzer, S.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
MAGNE TVEIT, Kjell, GUREN, Tormod, FOKSTUEN, Tone, HANSEN, Flemming, HOFSLI, Eva, BIRKEMEYER, Elke, JOHNSSON, Anders, STARKHAMMAR, Hans, YILMAZ, Mette Karen, KELDSEN, Nina, BERIT ERDAL, Anne, DAJANI, Olav, GLIMELIUS, Bengt, DAHL, Olav, CHRISTOFFERSEN, Thoralf, PFEIFFER, Per, SORBYE, Halfdan, PYRHONEN, Seppo, SIGURDSSON, Fridbjorn, KURE, Elin, IKDAHL, Tone, SKOVLUND, Eva
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients
Sorbye, H., Knappskog, S., Grob, T., Venizelos, A., Amstutz, U., Hjortland, G.O., Lothe, I.M., Kersten, C., Hofsli, E., Sundlov, A., Elvebakken, H., Garresori, H., Couvelard, A., Svensson, J., Perren, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
Liposits, G., Skuladottir, H., Ryg, J., Winther, S.B., Möller, S., Hofsli, E., Shah, C-H., Poulsen Oestergaard, L., Berglund, A., Qvortrup, C., Osterlund, P.J., Johansen, J.S., Glimelius, B., Sorbye, H., Pfeiffer, P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
Liposits, G., Ryg, J., Skuladottir, H., Winther, S.B., Möller, S., Hofsli, E., Shah, C-H., Poulsen Oestergaard, L., Berglund, A., Qvortrup, C., Osterlund, P.J., Glimelius, B., Sorbye, H., Pfeiffer, P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
556P - Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Falk, P., Severin, M., Guren, M Gronlie, Österlund, P., Hofsli, E., Giwercman, A., Eberhard, J., Sorbye, H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
556PSex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Falk, P, Severin, M, Guren, M Gronlie, Österlund, P, Hofsli, E, Giwercman, A, Eberhard, J, Sorbye, H
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Falk, P., Severin, M., Guren, M Gronlie, Österlund, P., Hofsli, E., Giwercman, A., Eberhard, J., Sorbye, H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
P-81 Phase 3 study of MK4280A (coformulated favezelimab and pembrolizumab) versus standard of care in previously treated PD-L1–positive metastatic colorectal cancer (mCRC)
Kim, T., Taieb, J., Passhak, M., Kim, S., Geva, R., Hofsli, E., Perl, G., Yalcin, S., Hubert, A., Somer, B., Wong, Z., Wang, A., Leconte, P., Fogelman, D., Heinemann, V.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article